Consolidated Balance Sheets - USD ($) $ in Millions	Aug. 31, 2024	Feb. 29, 2024
Current
Cash and cash equivalents (note 2)	$ 171	$ 175
Short-term Investments	40	62
Accounts Receivable, after Allowance for Credit Loss, Current	150	199
Other receivables (note 3)	21	21
Income taxes receivable	4	4
Other current assets (note 3)	52	47
Assets, Current, Total	438	508
Restricted cash and cash equivalents (note 2)	17	25
Long-term investments (note 2)	37	36
Other long-term assets (note 3)	59	57
Operating Lease, Right-of-Use Asset	32	32
Property, plant and equipment, net (note 3)	17	21
Intangible assets, net (note 3)	136	154
Goodwill (note 3)	563	562
Assets	1,299	1,395
Current
Accounts payable	7	17
Accrued liabilities (note 3)	109	117
Income taxes payable (note 4)	28	28
Deferred revenue, current (note 10)	161	194
Total current liabilities	305	356
Deferred revenue, non-current (note 10)	28	28
Operating lease liabilities	38	38
Other long-term liabilities	1	3
Long-term notes (note 5)	195	194
Total liabilities	567	619
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 590,727,996 voting common shares (February 29, 2024 - 589,232,539)	2,964	2,948
Deficit	(2,219)	(2,158)
Accumulated other comprehensive loss (note 8)	(13)	(14)
Total shareholders' equity	732	776
Total liabilities and shareholders' equity	$ 1,299	$ 1,395
Common issued (in shares)	590,727,996	589,232,539
Common outstanding (in shares)	590,727,996	589,232,539